- Home
- GV vs NLSP Comparison
GV vs NLSP Comparison
Compare GV & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GV
- NLSP
- Stock Information
- Founded
- GV 2013
- NLSP 2015
- Country
- GV Canada
- NLSP Switzerland
- Employees
- GV N/A
- NLSP N/A
- Industry
- GV Other Consumer Services
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- GV Real Estate
- NLSP Health Care
- Exchange
- GV Nasdaq
- NLSP Nasdaq
- Market Cap
- GV 5.7M
- NLSP 5.2M
- IPO Year
- GV 2022
- NLSP 2021
- Fundamental
- Price
- GV $2.16
- NLSP $1.85
- Analyst Decision
- GV
- NLSP
- Analyst Count
- GV 0
- NLSP 0
- Target Price
- GV N/A
- NLSP N/A
- AVG Volume (30 Days)
- GV 275.6K
- NLSP 440.1K
- Earning Date
- GV 12-24-2024
- NLSP 12-31-2024
- Dividend Yield
- GV N/A
- NLSP N/A
- EPS Growth
- GV N/A
- NLSP N/A
- EPS
- GV 0.32
- NLSP N/A
- Revenue
- GV $9,380,985.00
- NLSP N/A
- Revenue This Year
- GV N/A
- NLSP N/A
- Revenue Next Year
- GV N/A
- NLSP N/A
- P/E Ratio
- GV $5.21
- NLSP N/A
- Revenue Growth
- GV 11.25
- NLSP N/A
- 52 Week Low
- GV $1.00
- NLSP $1.75
- 52 Week High
- GV $8.85
- NLSP $24.32
- Technical
- Relative Strength Index (RSI)
- GV 70.77
- NLSP 22.65
- Support Level
- GV $1.25
- NLSP $1.75
- Resistance Level
- GV $1.45
- NLSP $2.13
- Average True Range (ATR)
- GV 0.23
- NLSP 0.29
- MACD
- GV 0.10
- NLSP -0.03
- Stochastic Oscillator
- GV 58.98
- NLSP 4.23
About GV Visionary Education Technology Holdings Group Inc.
Visionary Holdings Inc is a private education providing company located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The company aims to provide access to secondary, college, undergraduate and graduate, and vocational education to students in Canada through technological innovation so that more people can learn, grow, and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the company has been serving and will continue to serve both Canadian and international students.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.